While the overall counts of CD3+, CD4+, and CD8+ T cells remained stable (data not shown), a marked increase in IFNγ expression was detected in circulating CD4+ cells (Figure 8A) and CD8+ T cells (Figure 8B) in patients with STS and melanoma 4 weeks after CPMV treatment. This evidence concerns the gene CD8A and melanoma.